title: [Why measure drug metabolites?].
authors.affiliation: Psykofarmakologisk avdeling, Diakonhjemmet Sykehus, 0319 Oslo. magnhild.hendset@diakonsyk.no
authors.forename: Magnhild
authors.initials: M
authors.lastname: Hendset
authors.forename: Monica
authors.initials: M
authors.lastname: Hermann
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000378:metabolism; D014150:Antipsychotic Agents / Q000378:metabolism; D003511:Cyclohexanols / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics; D004347:Drug Interactions; D016903:Drug Monitoring; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D010349:Patient Compliance; D004364:Pharmaceutical Preparations / Q000097:blood / Q000378:metabolism*; D010597:Pharmacogenetics; D018967:Risperidone / Q000378:metabolism; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003511:Cyclohexanols; D004364:Pharmaceutical Preparations; D000069470:Venlafaxine Hydrochloride; D003577:Cytochrome P-450 Enzyme System; D018967:Risperidone